These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 26517627)

  • 1. Clinicopathological characterisation of duodenal adenocarcinoma with high CD44 variant 9 expression.
    Maruyama Y; Uehara T; Daikuhara S; Kobayashi Y; Nakajima T; Matsumoto A; Tanaka E; Ota H
    Pathology; 2015 Dec; 47(7):647-52. PubMed ID: 26517627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancer.
    Aso T; Matsuo M; Kiyohara H; Taguchi K; Rikimaru F; Shimokawa M; Segawa Y; Higaki Y; Umeno H; Nakashima T; Masuda M
    PLoS One; 2015; 10(3):e0116596. PubMed ID: 25751671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.
    Kobayashi K; Matsumoto H; Matsuyama H; Fujii N; Inoue R; Yamamoto Y; Nagao K
    Oncol Rep; 2016 Nov; 36(5):2852-2860. PubMed ID: 27599396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell marker in circulating tumor cells: expression of CD44 variant exon 9 is strongly correlated to treatment refractoriness, recurrence and prognosis of human colorectal cancer.
    Katoh S; Goi T; Naruse T; Ueda Y; Kurebayashi H; Nakazawa T; Kimura Y; Hirono Y; Yamaguchi A
    Anticancer Res; 2015 Jan; 35(1):239-44. PubMed ID: 25550556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer.
    Wu CL; Chao YJ; Yang TM; Chen YL; Chang KC; Hsu HP; Shan YS; Lai MD
    BMC Cancer; 2015 Nov; 15():903. PubMed ID: 26572077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 variant 9 expression as a predictor for gastric cancer recurrence: immunohistochemical and metabolomic analysis of surgically resected tissues.
    Yamakawa Y; Kusuhara M; Terashima M; Kinugasa Y; Sugino T; Abe M; Mochizuki T; Hatakeyama K; Kami K; Yamaguchi K
    Biomed Res; 2017; 38(1):41-52. PubMed ID: 28239031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer.
    Kodama H; Murata S; Ishida M; Yamamoto H; Yamaguchi T; Kaida S; Miyake T; Takebayashi K; Kushima R; Tani M
    Br J Cancer; 2017 Jan; 116(2):186-194. PubMed ID: 27931044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma.
    Kakehashi A; Ishii N; Sugihara E; Gi M; Saya H; Wanibuchi H
    Cancer Sci; 2016 May; 107(5):609-18. PubMed ID: 26882440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9(+) cancer stem cells in ulcerative colitis-related cancer.
    Seishima R; Okabayashi K; Nagano O; Hasegawa H; Tsuruta M; Shimoda M; Kameyama K; Saya H; Kitagawa Y
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):487-93. PubMed ID: 26775891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 variant isoforms are involved in plasma cell adhesion to bone marrow stromal cells.
    Van Driel M; Günthert U; van Kessel AC; Joling P; Stauder R; Lokhorst HM; Bloem AC
    Leukemia; 2002 Jan; 16(1):135-43. PubMed ID: 11840273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of CD44+/CD24- tumor cell ratio in breast cancer.
    Liu C; Luo Y; Liu X; Lu P; Zhao Z
    Cancer Biother Radiopharm; 2012 Jun; 27(5):324-8. PubMed ID: 22702496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD44std and CD44v9 subpopulations in non-tumorigenic invasive SNU-423 cells present different features of cancer stem cells.
    Aguilar-Chaparro MA; Rivera-Pineda SA; Hernández-Galdámez HV; Piña-Vázquez C; Villa-Treviño S
    Stem Cell Res; 2023 Oct; 72():103222. PubMed ID: 37844417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis.
    Kiuchi S; Ikeshita S; Miyatake Y; Kasahara M
    Exp Mol Pathol; 2015 Feb; 98(1):41-6. PubMed ID: 25481101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between epidermal growth factor receptor and tumor stem cell markers CD44/CD24 and their relationship with prognosis in breast invasive ductal carcinoma.
    Zheng Z; Shao N; Weng H; Li W; Zhang J; Zhang L; Yang L; Ye S
    Med Oncol; 2015 Jan; 32(1):275. PubMed ID: 25429827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of moesin and CD44 is associated with poor prognosis in gastric adenocarcinoma.
    Jung WY; Kang Y; Lee H; Mok YJ; Kim HK; Kim A; Kim BH
    Histopathology; 2013 Oct; 63(4):474-81. PubMed ID: 23889297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulated CD44v9 expression inhibits the invasion of oral squamous cell carcinoma cells.
    Sato S; Miyauchi M; Kato M; Kitajima S; Kitagawa S; Hiraoka M; Kudo Y; Ogawa I; Takata T
    Pathobiology; 2004; 71(4):171-5. PubMed ID: 15263805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of CD44v9 and 8-OHdG in ovarian endometrioma and the benign endometriotic lesions adjacent to clear cell carcinoma.
    Niiro E; Kawahara N; Yamada Y; Yoshimoto C; Shimada K; Sudo T; Kobayashi H
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2260-2266. PubMed ID: 31411797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
    Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
    Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype.
    Ricardo S; Vieira AF; Gerhard R; Leitão D; Pinto R; Cameselle-Teijeiro JF; Milanezi F; Schmitt F; Paredes J
    J Clin Pathol; 2011 Nov; 64(11):937-46. PubMed ID: 21680574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.